19-10995004-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003072.5(SMARCA4):c.1593+3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003072.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.1593+3A>G | splice_region_variant, intron_variant | Intron 9 of 35 | ENST00000646693.2 | NP_001374212.1 | ||
SMARCA4 | NM_003072.5 | c.1593+3A>G | splice_region_variant, intron_variant | Intron 9 of 34 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.1593+3A>G | splice_region_variant, intron_variant | Intron 9 of 35 | NM_001387283.1 | ENSP00000495368.1 | ||||
SMARCA4 | ENST00000344626.10 | c.1593+3A>G | splice_region_variant, intron_variant | Intron 9 of 34 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
SMARCA4 | ENST00000643549.1 | c.1593+3A>G | splice_region_variant, intron_variant | Intron 9 of 34 | ENSP00000493975.1 | |||||
SMARCA4 | ENST00000541122.6 | c.1593+3A>G | splice_region_variant, intron_variant | Intron 10 of 34 | 5 | ENSP00000445036.2 | ||||
SMARCA4 | ENST00000643296.1 | c.1593+3A>G | splice_region_variant, intron_variant | Intron 9 of 33 | ENSP00000496635.1 | |||||
SMARCA4 | ENST00000644737.1 | c.1593+3A>G | splice_region_variant, intron_variant | Intron 9 of 33 | ENSP00000495548.1 | |||||
SMARCA4 | ENST00000589677.5 | c.1593+3A>G | splice_region_variant, intron_variant | Intron 10 of 34 | 5 | ENSP00000464778.1 | ||||
SMARCA4 | ENST00000643995.1 | c.1005+3A>G | splice_region_variant, intron_variant | Intron 6 of 31 | ENSP00000496004.1 | |||||
SMARCA4 | ENST00000644963.1 | c.237+3A>G | splice_region_variant, intron_variant | Intron 2 of 27 | ENSP00000495599.1 | |||||
SMARCA4 | ENST00000644065.1 | c.321+3A>G | splice_region_variant, intron_variant | Intron 2 of 26 | ENSP00000493615.1 | |||||
SMARCA4 | ENST00000642350.1 | c.81+3A>G | splice_region_variant, intron_variant | Intron 1 of 26 | ENSP00000495355.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant is associated with altered splicing resulting in unknown protein product impact (Invitae). ClinVar contains an entry for this variant (Variation ID: 486476). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 9 of the SMARCA4 gene. It does not directly change the encoded amino acid sequence of the SMARCA4 protein. It affects a nucleotide within the consensus splice site. -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.1593+3A>G intronic variant results from an A to G substitution 3 nucleotides after coding exon 8 in the SMARCA4 gene. This nucleotide position is well conserved in available vertebrate species. Using two different splice site prediction tools, this alteration is predicted by BDGP to abolish the native splice donor site, but is predicted to weaken (but not abolish) the efficiency of the native splice donor site by ESEfinder; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at